- Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:7S-37S. https://doi.org/10.1378/chest.12-2377
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61: 69-90. https://doi.org/10.3322/caac.20107
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29. https://doi.org/10.3322/caac.20138
- Gomes M, Teixeira AL, Coelho A, Araujo A, Medeiros R. Inflammation and lung cancer oxidatives Stress, ROS, and DNA damage. In: Ahmad SI, eds. Reactive Oxygen Species in Biology and Human Health. London: CRC Press; 2016
- Nikolić I, Kukulj S, Samaržija M, Jeleč V, Žarak M, Orehovec B, Taradi I, Romic D, Kolak T, Patrlj L. Neutrophil-to-lymphocytes and platelet-to-lymphocytes ratio help identify patients with lung cancer, but don't differentiate between lung cancer subtypes. Croat Med J. 2016; 57: 287–92. https://doi.org/10.3325/cmj.2016.57.287
- Heron M. Deaths: Leading causes for 2013. Natl Vital Stat Rep 2016; 65 :1-94
- Yoon HI, Kwon OR, Kang KN, Shin YS, Shin HS, Yeon EH, Kwon KY, Hwang I, Jeon YK, Kim Y, Kim CW. Diagnostic value of combining tumors and inflammatory markers in lung cancer. J Cancer Prev. 2016;21:187–193. https://doi.org/10.15430/JCP.2016.21.3.187
- Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;19(420):860-867. https://doi.org/10.1038/nature01322
- Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A. Are neutrophils/lymphocytes and platelets / lymphocytes rates in patients with non-small cell lung cancer associated with treatment response and prognosis?. Asian Pac J Cancer Prev. 2013;14:5237–42. https://doi.org/10.7314/apjcp.2013.14.9.5237
- Karagöz B, Alacacioǧlu A, Bilgi O, Demirci H, Özgün A, Erikçi AA, Sayan O, Yilmaz B, Kandemir EG. Platelet count and platelet distribution width increases in lung cancer patients. Anatol J Clin Investig. 2009;3:32–4
- Mikogami T, Kunimura T, Omatsu M, Shiokawa A, Nagai T, Hirota Y, Koji S, Ohike N, Kitami A, Suzuki T. Neutrophil-rich pulmonary carcinoma: Clinicopathological characteristicsand cytokine expression and their relationship with lymph node metastasis. Showa Univ J Med Sci. 2014;26:9-16. https://doi.org/10.15369/sujms.26.9
- Aldarouish M, Wang C. Trends and advances in tumor immunology and lung cancer immunotherapy. J Exp Clin Cancer Res.2016;35:157. https://doi.org/10.1186/s13046-016-0439-3
- Indonesian Ministry of Health. National Guidelines for Medical Services: Lung Cancer. Jakarta: Indonesian Ministry of Health; 2017. p. 1–75. [In Indonesia]
- Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends. J Thorac Oncol, 2008;3:819–31. https://doi.org/10.1097/JTO.0b013e31818020eb
- Hruba F, Fabiánová E, Bencko V, Cassidy A, Lissowska J, Mates D, Rudnai P, Zaridze D, Foretova L, Janout V, Dabrowska NS, Brennan P, Boffrtta P. Socioeconomic indicators and risk of lung cancer in central and eastern Europe. Cent Eur J Public Health. 2009;17: 115–21
- Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J, 2009;34:380-386. https://doi.org/10.1183/09031936.00144208
- Rahal Z, El Nemr S, Sinjab A, Chami H, Tfayli A, Kadara H. Smoking and lung cancer: A geo-regional perspective. Front Oncol. 2017;7:194. https://doi.org/10.3389/fonc.2017.00194
- Zhu H, Zhang S. Body mass index and lung cancer risk in never smokers: a meta-analysis. BMC Cancer. 2018;18:635. https://doi.org/10.1186/s12885-018-4543-y
- Iyer S, Roughley A, Rider A, Taylor-Stokes G. The symptom burden of non-small cell lung cancer in the USA: A real-world cross-sectional study. Support Care Cancer. 2014;22:181-7. https://doi.org/10.1007/s00520-013-1959-4
- Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144:646–74. https://doi.org/10.1016/j.cell.2011.02.013
- Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. 2010;185:2273–
- https://doi.org/10.4049/jimmunol.1000901
- Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer 2016;16:431–46. https://doi.org/10.1038/nrc.2016.52
- Zhang X, Ran Y. Prognostic role of elevated platelet count in patients with lung cancer: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8:5379–87
- Peng B, Wang YH, Liu YM, Ma LX. Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: A systemic review and meta-analysis. Int J Clin Exp Med. 2015;8:3098-106
- Kargl J, Busch SE, Yang GHY, Kim KH, Hanke ML, Metz HE, Hubbard JJ, Lee SM, Madtes DK, McIntosh MW, Houghton AM. Neutrophils dominate the immune cell composition in non-small cell lung cancer. Nat Commun. 2017;8:14381. https://doi.org/10.21037/jtd.2017.04.55
- Kemal Y, Yucel I, Ekiz K, Demirag G, Yilmaz B, Teker F, Ozdemir M. Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis. Asian Pac J Cancer Prev. 2014;15:2651-2654. https://doi.org/10.7314/apjcp.2014.15.6.2651
Last update:
No citation recorded.
Last update:
No citation recorded.
Copyright (c) 2024 Journal of Biomedicine and Translational Research

This work is licensed under a
Creative Commons Attribution-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Journal of Biomedicine and Translational Research Diponegoro University as publisher of the journal.
Copyright encompasses non-exclusive rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms and any other similar reproductions, as well as translations.
Journal of Biomedicine and Translational Research Diponegoro University, the Editors and the Advisory International Editorial Board make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in the Journal of Biomedicine and Translational Research Diponegoro University (JBTR) are sole and exclusive responsibility of their respective authors and advertisers.
The Copyright Transfer Form can be downloaded here: [Copyright Transfer Form JBTR]
The copyright form should be signed originally and send to the Editorial Office in the form of original mail, scanned document or fax :
Journal of Biomedicine and Translational Research Faculty of Medicine, Diponegoro University
Jl. Prof. Soedarto, Kampus UNDIP Tembalang, Semarang, Central Java, Indonesia 50275, Telp.: +62-24-8454714, Fax.: +62-24-8454714
Email: jbtr@fk.undip.ac.id